Medicare Will Allow Price Bargaining for a Handful of Drugs

(Bloomberg) -- The Trump administration issued a regulation Thursday that it says will lower drug prices and reduce patient costs by opening up price negotiations for some pharmaceuticals.

• The regulation allows private insurers that cover about 20 million seniors to bargain over drugs administered in doctor’s offices or hospital outpatient clinics, the section of the program known as Part B. The rule scraps a plan that would have caused companies that raise the cost of certain drugs to lose protections that guarantee Medicare coverage.

Key Insights

Know More

©2019 Bloomberg L.P.